Late Bacterial Endocarditis in an Intravenous Drug User With an Amplatzer Septal Occluder

Tex Heart Inst J. 2020 Aug 1;47(4):311-314. doi: 10.14503/THIJ-18-6903.

Abstract

Infective endocarditis of a fully endothelialized cardiac prosthesis, and especially the late presentation of endocarditis, challenges our current understanding of device-related complications. Late bacterial endocarditis associated with the Amplatzer Septal Occluder, a device frequently used to close atrial septal defects, has been documented only rarely. We report the case of an intravenous drug user who had late infective endocarditis associated with his Amplatzer Septal Occluder, secondary to methicillin-sensitive Staphylococcus aureus bacteremia nearly 14 years after device insertion. The patient recovered after surgical excision and débridement of the vegetative mass, which may be the first time that a surgical approach has been taken to treat this condition. This report corroborates the need for late screening of high-risk patients who have septal occluder devices.

Keywords: Cardiac surgical procedures; endocarditis, bacterial/complications/diagnosis/etiology; heart septal defects, atrial/pathology; prostheses and implants; prosthesis-related infections/diagnosis/surgery; risk factors; septal occluder devices/adverse effects; treatment outcome.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cardiac Catheterization / methods
  • Echocardiography, Transesophageal
  • Endocarditis, Bacterial / diagnosis
  • Endocarditis, Bacterial / etiology*
  • Endocarditis, Bacterial / microbiology
  • Humans
  • Male
  • Septal Occluder Device*
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / etiology*
  • Staphylococcal Infections / microbiology
  • Substance Abuse, Intravenous / complications*